International Stem Cell (OTCMKTS:ISCO) Share Price Passes Above Two Hundred Day Moving Average – Here’s Why

International Stem Cell Corp. (OTCMKTS:ISCO)’s stock price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.14 and traded as high as $0.1750. International Stem Cell shares last traded at $0.1750, with a volume of 192 shares traded.

International Stem Cell Price Performance

The company has a market cap of $1.40 million, a PE ratio of -8.75 and a beta of 0.24. The stock has a 50 day simple moving average of $0.15 and a two-hundred day simple moving average of $0.14.

About International Stem Cell

International Stem Cell Corporation (OTCMKTS:ISCO) is a biotechnology company focused on the development and commercialization of human parthenogenetic stem cells (hpSC) for therapeutic and research applications. Parthenogenetic stem cells are derived from unfertilized human eggs and offer a scalable, ethically noncontroversial source of pluripotent cells. ISCO’s proprietary hpSC lines can be directed to differentiate into a wide variety of cell types, enabling preclinical programs in areas such as neurodegenerative disease, liver disease, diabetes and corneal regeneration.

In addition to its therapeutic pipeline, International Stem Cell maintains a research products division that supplies hpSC lines, differentiated cell populations and media formulations to academic institutions, biotechnology companies and contract research organizations.